Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2Sign in
← Cases

LATS1

RBC: LATS1 · Substrate: SGKtide · medium confidenceReferenceDerived

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Netarsudil93.80.68
Capivasertib87.70.64
Baricitinib86.40.62
Ruxolitinib71.20.59
Pacritinib68.30.45
Midostaurin64.30.50
Darovasertib54.50.72
Defactinib44.60.45
Brigatinib38.60.51
Abrocitinib29.60.58
Gilteritinib26.90.51
Abemaciclib26.60.56
Sunitinib23.70.52
Pralsetinib20.00.64
Pirtobrutinib16.20.66

Known variants

No variants catalogued.
Open in new tab